Tecentriq 1,200 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB26FX1JQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,509
Award facts
- Contract value 100% obligated
- $19,508.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $19.5K by the Defense Logistics Agency on October 8, 2025, for the supply of Tecentriq 1,200 mg/20 mL vials. The delivery order, which carries an ultimate completion date of October 30, 2025, was issued without a set-aside designation, allowing the vendor to compete on an unrestricted basis. This award represents a single delivery order under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the DLA valued at $500M and valid through November 2026.
The delivery order supports the DLA's pharmaceutical supply operations, which provide medical products to Department of Defense healthcare facilities worldwide. Tecentriq, an oncology therapeutic agent, is among the company's extensive portfolio of branded and generic prescription drugs, biologics, and specialty medications supplied to military health systems. DMS Pharmaceutical Group's established presence in federal pharmaceutical procurement, demonstrated through consistent contract awards with the DLA across diverse product categories, positions the company as a key supplier within the federal pharmaceutical supply chain serving defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FX1JQ?
SPE2DB26FX1JQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 8, 2025.
How much is contract SPE2DB26FX1JQ worth?
The government has obligated $19,509 on SPE2DB26FX1JQ.
Is contract SPE2DB26FX1JQ an order under another contract?
Yes. SPE2DB26FX1JQ is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB26FX1JQ competed?
The extent of competition for SPE2DB26FX1JQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award